probiotics
Biopharma companies are currently developing Live Biotherapeutic Products. We discussed this topic with Morten Isaksen (BIO-ME).
Important goal reached by the Novara-based pharmaceuticals company, specialised in the production and marketing of live biotherapeutic products.
The report of the main topics highlighted at the event on 12 October 2022 related to Probiotics, Prebiotics and the Microbiome.
Probiotic supplements with ethanol-metabolizing activity may help reduce the disease burden of excessive alcohol consumption.
Simone Guglielmetti (University of Milan) discusses the use of inactivated microbes as alternative to live probiotics.
The findings of a small clinical trial suggest that probiotic treatment could be used in combination with antidepressant medication to treat clinical depression.
Harnessing the human-microbial synergy during pregnancy in the form of probiotics has been shown to impact maternal health and the health of the developing fetus.
Patrice Cani (Université catholique de Louvain) discusses the future of Akkermansia municiphila.
George Paraskevakos (International Probiotics Association) discusses the challenges on microbiome space.
Stephen Daniells (William Reed Business Media Ltd.) discusses what emerged at Probiota Global 2022.
